Value-Based Payment Models in Oncology: Deloitte Research on Impact of New Payment Models

Home Page  | Upcoming Events  |  Past Events  |  Registration  |   Attendees  |  More Info  |  LinkedIn
Value-Based Payment Models in Oncology: Deloitte Research on Impact of New Payment Models 
  Download Brochure Need a brochure? Download the event brochure including a registration form you can fax or mail

The costs of treating cancer are rising—approximately $124.6 billion in 2010 in the United States and projected to grow to $158 billion to $173 billion by 2020. Increased spending on cancer care can be attributed to a number of factors, including an aging population, growth in the number of individuals with insurance coverage, earlier diagnoses, and longer survival rates. Advances have been made in surgeries, radiation therapies, and medications—including advanced immunotherapies and targeted therapeutics. But these advancements are paralleled with rising treatment costs.

Today, many health plans, health systems, and oncology groups have begun experimenting with value-based payment models to control rising costs, reduce unexplained variation in care, and improve patient outcomes. Four value-based payment models are being tested in the commercial market: (1) Financial incentives for adhering to clinical pathways; (2) Patient-centered medical homes (PCMHs); (3) Bundled payments; and (4) Specialty accountable care organizations (ACOs). In addition, CMS recently launched the Oncology Care Model (OCM), a 2-part payment system, resembling a PCMH and a bundled payment model. Many of these models target drug spending.

The Deloitte Center for Health Solutions recently interviewed stakeholders from health plans, provider groups, and clinical pathway developers that are participating, supporting, or evaluating oncology payment models to understand what approaches are perceived to be working, and what the early results (financial and clinical) have been. They also sought to understand how these payment models affect the use of new treatments.

With rapid advances in diagnostics, precision medicine, and immunotherapy, how can a standardized payment model be defined that leaves room for innovation? Deloitte research reveals that many organizations are experimenting with value- based payment models that aim to balance the competing goals of controlling costs and allowing access to advances in treatment. While none of the participating organizations claimed to have solved this equation, all of them indicated that they had seen early signs of success and were working to evolve and expand these models.

Please join us Wednesday, May 31st 2017 at 12 PM Eastern as Deloitte's Sonal Shah, PharmD and Bushra Naaz explain Deloitte's insights and research findings in the HealthcareWebSummit event: Value-Based Payment Models in Oncology: Deloitte Research on Impact of New Payment Models.

Learning Objectives

After attending this webinar, attendees will be able to:

  1. Learn results from the Deloitte Center for Health Solutions’ primary research on the impact of value based payment models in oncology.
  2. Ascertain the prevalence and evolution of the types of payment models being implemented.
  3. Understand how these value-based payment models influence drug use and spending.
  4. Explore preliminary results and financial savings from these payment models.
  5. Consider how new value-based payment models can pose challenges for adoption of new treatments.
  6. Identify barriers that may continue to exist around tailoring payment models to cancer sub-types, capturing data to evaluate models, and bringing models to scale.
  7. Plus engage in interactive learning through online question submission, attendee feedback and opportunity for follow up questions, and networking with attendees, faculty and other professionals through dedicated LinkedIn group.
Who Should Attend

Interested attendees would include:

  • C-Suite Executives
  • Value Based Payment Executives and Staff
  • Healthcare Innovation, Transformation and Reform Executives
  • Medical Directors
  • Care Management Executives and Staff
  • Population Health Executives
  • Provider Network Executives and Staff
  • Policy Executives and Staff
  • Planning and Strategic Executives and Staff
  • Business Intelligence Executives and Staff
  • Other Interested Parties

Attendees would represent organizations including:

  • Hospitals and Health Systems
  • Health Plans
  • Medical Groups
  • Accountable Care Organizations
  • Provider Networks
  • Other Healthcare Providers
  • Life Sciences Organizations
  • Government
  • Solutions Providers
  • Associations, Institutes and Research Organizations
  • Media
  • Other Interested Organizations
Value-Based Payment Models in Oncology: Deloitte Research on Impact of New Payment Models
  Individual Registration Fee: $195. Post-event materials, with video syncing slides and recorded audio, plus presentation pdf file: $45 for attendees; $260 for non-attendees after the event. Register online or download the event brochure. Attendees will also receive a complimentary three month trial subscription to Value Based Payment News (new subscribers only).
Register Now   Corporate Site licensing also available. Click here to register or call 209.577.4888 We look forward to your participation in this event!
Sonal Shah

Sonal Shah, PharmD
Senior Manager
Deloitte Center for Health Solutions

  Sonal Shah, PharmD, is a senior manager at the Deloitte Center for Health Solutions, where she leads research projects on emerging trends, challenges, and opportunities in healthcare. Dr. Shah’s research is focused on research and development and innovation, value-based care, and the impact of healthcare reform to life sciences companies.

Dr. Shah has an MBA in Health Care Management from the University of Pennsylvania - The Wharton School, and a PharmD. from Rutgers, The State University of New Jersey-New Brunswick.

Bushra Naaz

Bushra Naaz
Deloitte Center for Health Solutions

  Bushra Naaz is a Manager with the Center for Health Solutions at Deloitte. She is a Seasoned professional with over nine years of experience in Consulting, Strategy and Business Research in the Life Sciences and Healthcare sector.

She holds a Post Graduate Diploma in International Business from the Symbiosis institute of Management Studies.
HealthcareWebSummit events from MCOL  
1101 Standiford Ave. Suite C-3 Modesto, CA 95350
Phone 209.577.4888  | e-Mail  |  Fax 209.577.3557
copyright , MCOL All rights reserved. Terms of Use apply to this site and participation in events.